Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
June 30, 2024 30.78M
March 31, 2024 43.91M
December 31, 2023 63.90M
September 30, 2023 80.89M
June 30, 2023 107.51M
March 31, 2023 136.40M
December 31, 2022 163.99M
September 30, 2022 178.00M
June 30, 2022 201.42M
March 31, 2022 131.05M
December 31, 2021 153.93M
September 30, 2021 155.26M
June 30, 2021 179.55M
March 31, 2021 197.93M
December 31, 2020 88.55M
September 30, 2020 55.20M
June 30, 2020 45.55M
March 31, 2020 34.40M
December 31, 2019 43.31M
September 30, 2019 24.33M
June 30, 2019 37.34M
March 31, 2019 47.90M
Date Value
December 31, 2018 45.90M
September 30, 2018 41.66M
June 30, 2018 54.55M
March 31, 2018 66.90M
December 31, 2017 37.89M
September 30, 2017 39.83M
June 30, 2017 45.91M
March 31, 2017 50.86M
December 31, 2016 40.97M
September 30, 2016 48.46M
June 30, 2016 58.46M
March 31, 2016 67.73M
December 31, 2015 73.55M
September 30, 2015 60.45M
June 30, 2015 67.69M
March 31, 2015 33.19M
December 31, 2014 38.66M
September 30, 2014 47.94M
June 30, 2014 -138.50M
March 31, 2014 -157.98M
December 31, 2013 -137.01M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

30.78M
Minimum
Jun 2024
201.42M
Maximum
Jun 2022
110.08M
Average
107.51M
Median
Jun 2023

Shareholders Equity (Quarterly) Benchmarks

InflaRx NV 88.06M
BioNTech SE 21.35B
Immatics NV 415.78M
CureVac NV 403.61M
ATAI Life Sciences NV 167.89M

Shareholders Equity (Quarterly) Related Metrics